SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-105686
Filing Date
2016-03-17
Accepted
2016-03-17 07:38:13
Documents
18
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a16-5330_120f.htm 20-F 1814878
2 EX-4.3 a16-5330_1ex4d3.htm EX-4.3 52774
3 EX-4.4 a16-5330_1ex4d4.htm EX-4.4 406144
4 EX-4.28 a16-5330_1ex4d28.htm EX-4.28 215557
5 EX-4.29 a16-5330_1ex4d29.htm EX-4.29 260032
6 EX-4.30 a16-5330_1ex4d30.htm EX-4.30 439956
7 EX-4.31 a16-5330_1ex4d31.htm EX-4.31 260531
8 EX-4.32 a16-5330_1ex4d32.htm EX-4.32 454210
9 EX-4.33 a16-5330_1ex4d33.htm EX-4.33 292038
10 EX-4.34 a16-5330_1ex4d34.htm EX-4.34 1599745
11 EX-4.35 a16-5330_1ex4d35.htm EX-4.35 77357
12 EX-4.36 a16-5330_1ex4d36.htm EX-4.36 357816
13 EX-12.1 a16-5330_1ex12d1.htm EX-12.1 10627
14 EX-12.2 a16-5330_1ex12d2.htm EX-12.2 10333
15 EX-13.1 a16-5330_1ex13d1.htm EX-13.1 5336
16 EX-13.2 a16-5330_1ex13d2.htm EX-13.2 5345
17 EX-15.1 a16-5330_1ex15d1.htm EX-15.1 4183
18 GRAPHIC g53301kg01i001.gif GRAPHIC 2325
  Complete submission text file 0001104659-16-105686.txt   6271377
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-37368 | Film No.: 161511247
SIC: 2836 Biological Products, (No Diagnostic Substances)